Search hospitals > Maryland > Annapolis
Anne Arundel Medical Center
Claim this profileAnnapolis, Maryland 21401
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
116 reported clinical trials
14 medical researchers
Summary
Anne Arundel Medical Center is a medical facility located in Annapolis, Maryland. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Anne Arundel Medical Center is involved with conducting 116 clinical trials across 161 conditions. There are 14 research doctors associated with this hospital, such as Adam J. Goldrich, Young J. Lee, Mary E. Young, and Feras Abdul Khalek.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
2Lung Cancer
Global LeaderStage II
Stage I
Stage III
Top PIs
Adam J. GoldrichUniversity of Maryland Shore Medical Center at Easton5 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
13 reported clinical trials
29 drugs studied
Young J. LeeAnne Arundel Medical Center2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
5 reported clinical trials
14 drugs studied
Mary E. YoungAnne Arundel Medical Center3 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
5 reported clinical trials
11 drugs studied
Feras Abdul KhalekAnne Arundel Medical Center11 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
4 reported clinical trials
8 drugs studied
Clinical Trials running at Anne Arundel Medical Center
Lung Cancer
Breast Cancer
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Brain Tumor
Multiple Myeloma
ALK Gene Rearrangement
Breast cancer
Squamous Cell Carcinoma
Relapse
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Anne Arundel Medical Center?
Anne Arundel Medical Center is a medical facility located in Annapolis, Maryland. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Anne Arundel Medical Center is involved with conducting 116 clinical trials across 161 conditions. There are 14 research doctors associated with this hospital, such as Adam J. Goldrich, Young J. Lee, Mary E. Young, and Feras Abdul Khalek.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.